Ruti Aga's Six-Year Ban: How a Forged Prescription Turned a Glucocorticoid Case into Career Death — A Full Ledger Audit

September 10. That date is now written in Ruti Aga's ledger in ink, not pencil. The decision announced by the Athletics Integrity Unit (AIU) on Thursday carried a two-year sanction for what we call in athletics 'presence' — the finding of a prohibited substance in the body. And four years for what we call 'tampering' — the attempt to mislead an investigation. Add them up: six years.

I have sat between stopwatch and results sheet for forty-five years. When I first logged every split of P.T. Usha's finals into my hardbound register at Seoul 2026, nobody told me that one day I would be writing cases where not the stopwatch but documents determine how long an athlete can run. Ruti Aga's case is exactly that. There is no mark here, no split, no wind reading. Only dates, documents, and a charge that begins with a painkiller and ends with a career death.

Let me first clear up the fact that the media has garbled. News reports are calling methylprednisolone a 'prohibited steroid.' This is wrong, and the error blurs the legal nuance of this entire case. Methylprednisolone is a glucocorticoid — WADA Prohibited List class S9. It is not an anabolic steroid (class S1). And this distinction is not trivial. Under the current List, S9 glucocorticoids are prohibited only in-competition — by injection, oral, or rectal routes. A knee injection given out-of-competition is entirely legal. It becomes a violation only if residues are found in an in-competition sample.

What this means is that the entire case hinged on two things — the route of the injection and its timing relative to the competition. Not on 'steroid use.' A trained team doctor, a documented medical record, and observance of WADA's route-specific washout period — with these three things, this case could have held up even in a hearing. But when you forge the prescription yourself, you burn the one defence that could have been real.

The Chinese Half Marathon: Where the Result Wasn't Recorded, But the Sample Was

March. A half marathon in China, which Aga won. Beyond the AIU statement, the information we have about this race is minimal. No mark, no split, no field strength. The source text says only that she won a half marathon in China in March and that a positive sample followed.

Here I must return to an old habit of mine. I always say — count the attempts before you count the medals. In this case we can count neither attempts nor marks. So the question is: can we draw any performance conclusion?

No. And that is the greatest irony of this case. Athletics news is usually built on times. This one is built on paper, not times. But one fact we do learn about performance: she won that race. That means it was a World Athletics Label-tier road race with a strong women's field and in-competition testing. Otherwise no AIU sample would exist at all.

The testing window for road races opens at 23:59 the day before the race. This is a technical point, but it is decisive in this case. If the knee injection was given days before the race and the washout period was not observed, residues would be found in-competition. If the injection had been given after the race, no case would exist. So the case that was built is a case of a timing error and a route error — not of intent, but of management.

I must record another observation here. China's label-race circuit has become a lucrative, low-risk income tier for East African marathoners. Between Majors, these races are a good source of appearance fees. But now this same circuit has become the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are now colliding in the same race.

And one thing no report has stated, but which is standard AIU practice: the result and prize money of the competition where the sample was collected are automatically annulled. That means the March half marathon victory, its prize money, and any ranking points accrued afterward — all void. The source text doesn't say so, but the ledger does.

The Knee, a Fake Clinic, and a Family 'Doctor'

Now the part that separates this case from ordinary doping cases.

Aga's defence was that she had a knee injury and took methylprednisolone for treatment. This argument is medically entirely credible. Intra-articular or peri-articular methylprednisolone for knee synovitis is a standard sports-medicine treatment in distance runners. Every experienced marathoner carries a version of this knee story.

But then comes the part where the story breaks. The prescription she submitted was from a clinic that did not exist. The 'doctor' who wrote it was a family member with no medical registration. And he claimed to have used 'an old prescription pad from a former workplace' — which the clinic explicitly disowned.

Three independent verification failures. One by one.

Here I write from an old habit: protocol is what we agreed to while we were still calm. Aga had no credentialed team physician. No TUE infrastructure. No documented medical records. When the crisis came, the solution became fabricating a document, not treatment. This is an individual ethical failure, but it is also a systemic management failure.

In East African road-running entourages, this is not an isolated event. Training camps, agents, and informal medical networks — this is an ecosystem in which fabricating a fake prescription is as easy as filing a race entry. And AIU enforcement has now shifted from 'detection' to 'document verification.' Aga's case is proof of that shift.

Two Plus Four: The Arithmetic That Tells Us What the Panel Thought

Now to the part I like most — the arithmetic of the sanction.

Two years for 'presence.' Four years for 'tampering.' Six total.

This structure is standard, not exceptional. Under the WADA Code, four years is the standard sanction for tampering. And two years for presence means the panel found the substance falls in the 'Specified Substance' category and that intentional fraud was not proven. Glucocorticoids fall in this category.

But there is a subtlety here. The Code provides for a 'no significant fault' mitigation, which could have reduced the sanction. A two-year sanction means the panel rejected that relief. Why? Because the forged prescription is itself circumstantial evidence of concealment intent. Had intent been clean, relief would have been granted. The forgery closed the door to relief.

Here is a paradox I want to record. The forged document is itself evidence of concealment intent, yet it did not escalate the presence sanction. Meaning the panel viewed the two matters separately — substance presence is one thing, document forgery another. This is legally correct, but practically it tells us that had she not forged, she might have received less than two years, or perhaps no sanction at all.

Now the most crucial fact. The ban is backdated to September 10. Meaning the provisional suspension period was credited against the sanction. Many read this as relief. It is not relief. It is only procedure. In real life the athlete gains nothing. She was out from September 10 anyway, and her clock has been running from September 10.

And one point no one is writing: there is criminal exposure in this case too. Document forgery is a criminal offence. The AIU's jurisdiction is limited to sport. But referral to national authorities is possible. The source text makes no mention of it. It is an open question.

Three Major Podiums, One Tokyo Title, and a Closed Door

Now to the side the media has almost ignored — the athlete who will no longer run.

Ruti Aga, age 32. Ethiopia. 2026 Tokyo Marathon winner. Second place at three World Marathon Majors. Second at Berlin 2026, where her personal best, per my recollection, was around 2:18:34. Tokyo 2026 victory, around 2:20:40. These figures are not in the source text; they are from my own records.

This is the record of a genuinely elite marathoner. Running in the 2:18-2:20 range is special even in Ethiopia, though it is not that country's deepest layer. Ethiopia has several women running under 2:16. The world record has reached around 2:12.

So the question: what effect will this ban have on Ethiopia's national team?

None. This may sound harsh, but it is true. Ethiopia's women's marathon depth is such that a 2:18 runner is not automatically selected for the national team. Aga's three Major podiums were commercial-tier results, not championship conversions. Her departure does not reduce Ethiopia's medal capacity by a gram.

But for the athlete, this is the entire story. A six-year ban at age 32 means returning at 38. In Ethiopian women's marathon, a 38-year-old with a doping record is practically unselectable. This is a lifetime ban for elite purposes.

And here I must record my greatest concern. This sanction was not for the substance. It was for the document. A six-year ban for a glucocorticoid — which has no proven endurance-performance benefit — is a striking outcome. It will be cited as evidence of AIU rigour, and also as evidence of disproportionate enforcement against African road runners.

I do not have the answer. But the ledger records it.

The Second Column I Will Not Write

I know what is expected of me here — that I write about the federation, the management, the agent. That I say how a 32-year-old athlete had no credentialed team doctor. How informal medical networks push athletes toward forgery. How appearance-fee pressure forces injury concealment.

All of this is true. But I have learned in forty years that the second column — 'what we wished had happened' — belongs to the athlete, not the administrator. Aga made her own mistake. She submitted the forged prescription. She misled the investigation. No agent will go to jail in her place.

So I will not write the administrative indictment expected of me. I will record only this: the Ethiopian athletics federation issued no statement on this case. Only the AIU is in the source text. That silence is also a fact.

Looking Toward the Next Race

Three things emerge from this case, and all three are signals for the next race.

First, the label-race circuit is now a high-scrutiny zone. Road races in China, Japan, Korea that are a major income source for East African elites are now the AIU's most fertile testing ground. Results there will be questioned.

Second, the enforcement frontier has shifted. The question is no longer 'was the substance found.' The question is 'are the papers correct.' Forged prescriptions, altered documents, misleading statements — this is now the most common second charge in road-running doping cases.

Third, the price of management is now higher than the price of the substance. Aga would have received two years, perhaps less, had she told the truth. Six years came from the document. This is a lesson for every athlete who thinks the way out of trouble is to fabricate a defence.

At Seoul 2026, when I measured every split of Usha with my Seiko stopwatch, I believed the truth of sport lay in time. Now I know that sometimes the truth lies in paper — and the price of writing lies on paper is paid in time. Ruti Aga has paid that price. Six years of it. From September 10.